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ABSTRACT We examined the influence of glucocorticoid hormones on the proliferation of
cultured adult bovine aortic smooth muscle cells (BASM) using both primary mass cultures
and a cloned strain. Cloned BASM cells maintained on plastic culture dishes were inhibited
by -40% by dexamethasone treatment but showed no inhibition when grown on homologous
extracellular matrix (ECM) coated dishes. Dexamethasone inhibited growth of primary cultures
by 73% on plastic and by 45% on ECM. The inhibitory effect was specific for the glucocorti-
coids, dexamethasone, corticosterone, and cortisol and was not observed with progesterone,
aldosterone, estradiol or 17-a OH progesterone.
In cloned cells, the abolition of glucocorticoid inhibition by ECM was independent of
seeding density and serum concentration. The inhibition on plastic was dependent on serum
concentrations >1% and resulted in both a slow rate of proliferation and a lower saturation
density. A specific subset of peptides detected on two-dimensional gels was induced by
glucocorticoids under growth inhibitory conditions but was not induced when the cells were
grown on ECM.
Primary cultures grown on ECM and exposed to Dulbecco's modified Eagle's Medium (DME)
containing high density lipoprotein and transferrin grew at 40% of the rate observed for
cultures exposed to DME with 10% serum. Both conditions showed growth inhibition of 70%
in the presence of dexamethasone. The addition of epidermal and platelet-derived growth
factors in DME containing high density lipoprotein and transferrin to cells grown on ECM
resulted in growth rates comparable to that observed with cultures exposed to 10% serum
and were inhibited 45% by dexamethasone. These results suggest that glucocorticoids inhibit
smooth muscle proliferation by decreasing the sensitivity of the cells to mitogenic stimulation
by high density lipoprotein when the cells are maintained on a homologous substrate.
Alterations in the control of vascular smooth muscle cell
proliferation are major factors in the development of athero-
sclerotic vessel disease (1). An understanding of factors that
either stimulate or inhibit vascular smooth muscle cell prolif-
eration is therefore a prerequisite to understanding and pos-
sibly controlling the pathogenesis of vascular disease. A major
contribution to our knowledge concerning the control of
vascular smooth muscle cell proliferation has come from the
use ofcultured aortic smooth muscle cells. Two growth factors
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found in serum, platelet-derived growth factor (PDGF)' (2),
and epidermal growth factor (EGF) (3), as well as a noncir-
culating fibroblast growth factor (FGF) (3), have been identi-
'Abbreviations used in this paper. DME, Dulbecco's modified Eagle's
medium; ECM, extracellular matrix; EGF, epidermal growth factor;
FGF, fibroblast growth factor; PDGF, platelet-derived growth factor;
DEX, dexamethasone; BASM, bovine aortic smooth muscle; HDL,
high density lipoprotein.
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endothelial cellshas been observed to stimulate smooth mus-
cle cell proliferation in culture (4). It also has been observed
that aortic smooth muscle cells, when grown on extracellular
matrix derived from corneal endothelial cells, can proliferate
maximally in the absence of PDGF provided HDL, EGF, and
insulin or somatomedin C are present (5). Because smooth
muscle cells in vivo are in constant contact with a variety of
extracellular components, these laterexperiments suggest that
the study of cultured smooth muscle cells when grown on
plastic surfaces in vitro may yield results that differ consider-
ably from that which occurs in vivo.
Although a large body of information has accumulated
concerningfactors that stimulate vascular smooth muscle cell
proliferation, little is knownabout factors which are inhibitory
to smooth muscle cell growth. Recently, a heparin-like sub-
stance secreted by endothelial cells has been characterized
that inhibits smooth muscle cell proliferation in vitro (6). We
have also reported that glucocorticoids inhibit the growth of
aortic smooth muscle but not aortic endothelial cells in culture
(7). This inhibitory response was observed in both primary
mass cultures and a cloned strain of bovine aortic smooth
muscle (BASM) cells. In addition, the noncirculating mitogen,
FGF, was found to totallyabolish the glucocorticoid-mediated
inhibition of smooth muscle cell proliferation (7).
These results suggest that glucocorticoids may selectively
inhibit the responsiveness of smooth muscle cells to the
mitogenic action of some component(s) in serum. Because of
these observations, and the finding that the extracellular sub-
strate can also modify the responsiveness of smooth muscle
cells to serum growth factors, we examined the influence of
glucocorticoids on the growth of BASM cells maintained on
a homologous extracellular matrix and in serum-free culture
media. The data show that glucocorticoids are growth inhib-
itory to BASM cells under all growth conditions examined
and support the proposition that myointimal hyperplasia may
be directly inhibited in vivo by these steroids.
MATERIALS AND METHODS
FGF and EGF were the generous gifts of Dr. D. Gospodarowicz. The FGF was
prepared as described (8) from bovine brain and solubilized at 50 jug/ml in
Dulbecco's modified Eagle's medium (DME-H16) containing 0.1% bovine
serum albumin. EGF was purified as described by Savage and Cohen (9).
Human high density lipoprotein (HDL) was purified from freshly drawn blood
by the method of Havell et al. (10). PDGF was purchased from Collaborative
Research Inc. (Lexington, MA). DME-H16, Fungizone, glutamine, penicillin,
streptomycin, trypsin-EDTA, and Hanks' balanced salt solution were obtained
from Grand Island Biological Co. (Grand Island, NY). Collagenase was pur-
chased from Worthington Biochemicals (Freehold, NJ). Calf serum (lot 2275)
was obtained from Sterile Systems Inc. (Logan, UT). ['sS]methionine (>1,000
Ci/mmol)was obtained from NewEngland Nuclear (Boston, MA).Acrylamide,
bis-acrylamide, and ammonium persulfate were obtained from Bio-Rad Labo-
ratories (Richmond, CA). SDS was a product of BDH Chemicals Ltd. (Poole,
England), and carrier ampholines were obtained from LKB Instruments (Rock-
ville, MD). All other chemical and reagents were purchased from Sigma
Chemical Co. (St. Louis, MO).
Cell Culture:
￿
Primary cultures of BASM cells were prepared from an
adult bovine aortic arch by collagenase digestion according to the method of
Chambley-Campbelletal. (11). Followingestablishment oftheprimaryculture,
cells were harvested by trypsinization (0.01% trypsin and 0.02% EDTA) and
cloned as described by Gospodarowicz et al. (12), in the presence of FGF.
Primary cultureswere used duringthe second to sixth passage (1 :50 split ratio).
Stock cultures of both primary and cloned BASM cells were maintained in
DME-H16 supplemented with 10% calf serum, penicillin (50 U/ml), strepto-
mycin (50 Ag/ml), and Fungizone (2.5 gg/ml) in a 5% C02-humidified incu-
bator at 37°C. Stocks of the cloned cells received 250 ng/ml FGF added every
otherday until they reached subconfluent densities.
For growth rate determinations, cells were seeded at an initial density of2.0
x 10` cells per 35 mm well in 6-well plates. 24 h later, any additions, i.e.,
hormones or growth factors, were made and, at the end of the growth period,
triplicate plates were trypsinized into single-cell suspensions, and the cells were
counted with a hemocytometer.
Preparation of ECM:
￿
Cultures of cloned BASM cells were used for
the preparation of ECM-coated tissue culture dishes as previously described
(13). These cells were grown to confluence, in the absence of FGF, washed
twice with phosphate-buffered saline, then exposed to 0.25 M NH,OH in
distilled water for 10 min at 25°C followed by several washes with distilled
water. The resulting ECM-coated dishes were stored at 4°C in distilled water
for up to 3 mo without loss oftheir growth-promoting activity.
Metabolic Labeling and Two-dimensional Gel Electropho-
resis:
￿
Cells were seeded into 2-cm' culture wells, either previously coated
with ECM or not, at a density of 5 x 10' cells/well. 6 h later, dexamethasone
(I uM) or FGF (250 ng/ml) was added and the cells were incubated for an
additional 48 h. Cultures were then washed twice in DME containing l0 juM
methionine and incubated in the same media for 1 h with 400 IACi/ml ['SS]-
methionine. Following the labeling period, the cells were washed twice with
PBS at 4°C and solubilized in 75 u1 ofO'Farell lysis buffer (14). 500,000 acid-
precipitable cpm were then fractionated on equilibrium two-dimensional gels
as previously described (14). The second dimension consisted of a 10-16%
exponential gradient of acrylamide in SDS. Following fixation and staining
(50% trichloroacetic, 0.1% Coomassie Blue), the gels were destained (7% acetic
acid), dried under vacuum, and autoradiographed for 10 d on Kodak NS2T
film.
RESULTS
Influence of Smooth Muscle ECM on
Glucocorticoid Responsiveness of BASM Cells
The proliferation of a primary mass culture as well as one
cloned strain of aortic smooth muscle cells was examined
over a 5-d period in the presence and absence of the synthetic
glucocorticoid DEX. As can be seen in Table I, neither the
mass culture nor the cloned strain showed differences in
plating efficiency on either the plastic substrate or ECM-
coated dishes. In addition, the mass culture grew almost
equally well on plastic culture dishes as on dishes covered
with ECM when the cells were not exposed to DEX. However,
mass cultures exposed to DEX and maintained on plastic
reached a density which was only 28% of that observed for
control cells. On matrix-coated dishes proliferation in the
TABLE I
Influence of Smooth Muscle ECMon the Growth Response of
Smooth Muscle Cells to Glucocorticoids
* Cells from either primary mass cultures or a cloned strain were
seeded into 35-mm dishes either coated or not with smooth
muscle ECM, as described in Materials and Methods, at a density
of 2 x 10' cells/dish. Some plates were then counted to determine
the plating efficiency at 6 h. DEX was added 24 h later and the
remainder of the cells were trypsinized and counted on the fifth
day. The mean and standard deviation of triplicate values for each
condition are shown.
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Conditions
Plastic (%
6 h
Cells/dish
of control)
5 d
x 10-^*
ECM (% of
6 h
control)
5 d
Mass culture
Control 1 .2 ± 0.2 51 .5 ± 2.5 1 .1 ± 0.1 55.1 ± 5.2
Dex (1 uM) 1 .1 ± 0.1 16.5 ± 1 .8 1 .0 ± 0.1 32.1 ± 2.5
(28%) (58%)
Clone BASM
Control 1 .3 ± 0.2 42.2 ± 4.0 1 .4 ± 0.2 82.5 ± 6.5
Dex (1pM) 1 .5±0.3 28.0±1 .5 1 .6±0.4 78.4±8.0presence of the glucocorticoid was 58% of the control. With
the cloned smooth muscle cells, the use ofECM-coated dishes
allowed a twofold increase in the final cell density during the
5-day growth period under control conditions. In the presence
of DEX, these cells grown on plastic were inhibited by 46%
but showed no significant glucocorticoid inhibition when
grown on ECM-coated dishes.
The steroid-induced inhibition of the mass culture shown
on Table 1 was also observed to be glucocorticoid specific and
was observed with the natural circulating bovine glucocorti-
coid, cortisol (62% inhibition). Corticosterone used at this
sameconcentration (0.1 juM) produced a 41 % inhibition while
progesterone consistently produced a slight stimulation of
growth (17%), possibly by antagonizing the effect of endoge-
nous cortisol in the calf serum. Aldosterone, estradiol, and
17a OH progesterone did not signfcantly inhibit smooth
muscle cell growth. The inhibition of aortic smooth muscle
cell growth appears to be glucocorticoid specific and is influ-
enced by the extracellular substrate on which the cells are
grown.
Effect of ECM, Serum, and Plating Density on the
Glucocorticoid-induced Inhibition of Cloned
BASM Cell Growth
The use of a cloned strain of BASM cells provided the
advantage that all cells in the culture were responding to the
growth conditions similarly. Because the results of Table I
showed that the ECM could totally overcome the inhibitory
influence of the glucocorticoid on the cloned strain, we used
this cloned strain to examine the kinetics, seeding density and
serum requirements of these growth responses.
The data of Fig. 1 show the kinetics of BASM cell growth
in the presence and absence of 1 AM DEX over a 9-d period
on either plastic or BASM-derived ECM-coated culture
dishes. In this experiment the plating efficiency measured at
6 h was the same on plastic and matrix. It is also clear that
there is no significant difference in the efficiency of plating as
a result of glucocorticoid treatment since the number of cells
at day 1 was the same in both presence and absence of DEX.
There is, however, a significant difference in the growth of
the cellson plasticand ECM, in termsofboth the proliferation
of the cells (i.e., doubling time), as shown by the slope of the
growth curve, and the saturation density reached. Further-
more, DEX was found not to be inhibitory to the growth of
these cells when they are plated on ECM-coated dishes, but
did significantly inhibit the growth ofthe cells on plastic. This
DEX-induced inhibition is characterized by a decreased pe-
riod of log-phase growth and an apparent lower saturation
density. The data of Fig. 1 are remarkably similar to our
earlier observations using FGF in place of ECM-coateddishes
(7). FGF stimulates the growth rate and saturation density of
this BASM clone when grown on plastic almost identical to
that shown here for cells grown on ECM-coated dishes. In
addition, FGF overcomes the glucocorticoid inhibition of
smooth muscle growth observed in its absence.
We next asked whether the glucocorticoid inhibition of
BASM cell growth was dependent on factors in the serum.
The data of Fig. 2A show the effect of reducing the serum
concentration on the growth (5 d) of BASM cells in the
presence and absence of DEX (1 jM) on plastic and ECM-
coated dishes. Although the ECM-stimulation of growth oc-
curs at all serum concentrations examined, the serum titration
53 6
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FIGURE 1
￿
Growth of BASM cells in the presence and absence of
DEX on plastic and ECM-coated dishes. Cloned BASM cells were
plated at 2 x 10° cells/35-mm tissue culture dishes which were
either coated or not with BASM-derived ECM. At the times shown,
cells were harvested by trypsinization and counted. This figure
shows the number of cells per 35-mm well over a 9-d growth
period. Solid symbols represent growth on ECM, and the open
symbols represent those grown on plastic. Cells grown in the
presence of 10-6 M DEX are shown in circles.
curves are nearly parallel for ECM and plastic, both showing
optimal growth at serum concentrations between 5 and 10%.
DEX did not affect BASM cell growth on ECM-coated dishes
at any serum concentration. For cells grown on plastic, how-
ever, DEX did inhibit growth at higher serum concentrations,
but not at concentrations <2.5% .
Because ECM-coated dishes appear to be "mitogenic" for
BASM cell growth, and as the response to serum growth
factors may be sensitive to the initial density at which the
cells are plated, we also examined the influence of plating
density on the growth of cloned BASM cells in the presence
and absence of DEX on both plastic and ECM-coateddishes.
The data of Fig. 2B show that cells grown on ECM-coated
dishes are far less sensitive to the initial plating density and
that DEX has no effect on their growth at any density. For
cellsgrown on plastic, however, there is a significant inhibition
of growth by DEX for cells plated at higher cell densities, but
a much smaller inhibition at lowerdensities. It is ofnote that
a common density limit appears in the data of Fig. 2A and
B, for cells grown on plastic in the presence of DEX. Under
these conditions, the growth of cells slows and begins to
plateau at a cell density of approximately 105 cells/well. The
reason or mechanism by which DEX results in a lower
saturation density is unclear.
Since DEX inhibits the growth of BASM cells grown on
plastic, and since ECM is mitogenic for these cells, it was of
interest to determine whether DEX could influence the mi-
togenic activity of the matrix material. BASM cells were
grown in the presence and absence of DEX for 11 d, and
ECM-coated dishes were prepared by alkali treatment in the
usual way. BASM cells plated on each of these ECM-coatedSerum (%)
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dishes were grown for 5 d and the number of cells per dish
was counted. The growth ofBASM cellson these DEX-treated
BASM cell-derived ECM was identical to that on non-DEX
treated matrix-coated dishes (data not shown). These results
indicate that DEX has no effect on the deposition of those
factors in the matrix which are required for its mitogenic
activity.
Matrix and FGF Overcome the Glucocorticoid
Regulation of Specific Protein Synthesis
- B
The glucocorticoid regulation of a variety of cellular func-
tions has been shown to be mediated by specific peptides
whose rates of synthesis are either stimulated or repressed by
the steroid. We have therefore examined this BASM clone to
determine whether conditions that abolish the glucocorticoid
inhibition of growth also abolish the regulation of specific
peptides by glucocorticoids.
Shown in Fig. 3 are two-dimensional electrophoretograms
of smooth muscle cells grown 48 h on either plastic or matrix
in the presence and absence of DEX. For comparison, gels
are also shown from an experiment where FGF was used
instead of matrix. In both cases, cells were pulse-labeled 1 h
with ["S]methionine, and the nascent peptides were solubi-
lized and then fractionated on two-dimensional gels. Of 10
peptides whose rate of synthesis was found to be regulated by
glucocorticoids, a specific set oftwo peptides at pI 5.5, molec-
ular weight 20,000 were consistently induced under condi-
tions where glucocorticoid-induced growth inhibition oc-
curred and were not induced by the steroid when the cells
were grown on ECM-coated dishes or in the presence of FGF,
conditions that abolish the glucocorticoid regulation of
growth. Because this experiment was performed on cells in
the early log-phase of growth, the glucocorticoid-regulated
peptides shown in Fig. 3 do not reflect a change induced by
the lower saturation density observed at later time points.
They may, however, correlate with the slower growth-rate
observed in glucocorticoid-treated BASM cells.
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FIGURE 2 The effect of se-
rum concentration and initial
plating density on BASM cell
growth. (A) Cells were plated
at a density of 2.0 x 10° cells/
35-mm well in tissue culture
dishes which were either
coated with ECM (solid sym-
bols) or not (open symbols)
in growth medium supple-
mented with 10% calf serum.
24 h later, the medium was
changed to medium supple-
mented with variable concen-
trations of serum as shown
and dexamethasone addition
at a final concentration of 10-6
M (circles). Shown are the
number of cells per well after
5-d growth. (B) BASM Cells
were plated in 35-mm dishes
at variable cell densities as
shown . The figure shows the
number of cells per dish 5 d
after plating. The symbols are
the same as in A
Growth of Primary Cultures of BASM Cells in
Serum-free Media
Recent reports have shown that both bovine aortic endo-
thelial and smooth muscle cellscan be grown on ECM-coated
dishes (derived from corneal endothelial cells) in the absence
ofserum if HDL is used to supplement the growth media (5,
15). To investigate the glucocorticoid response of primary
BASM cells in serum free media, we grew cells on both ECM-
coated and plastic tissue culture dishes under a number of
growth conditions as shown in Fig. 4. Confirming the result
shown in Table 1, the primary BASM cells grew equally well
on plastic and ECM in 10% serum, and the inhibition ofcell
growth by DEX occurred on both matrix and plastic, although
it was more marked on plastic (68% inhibition) than on
matrix (45% inhibition).
The addition of FGF (250 ng/ml) to primary BASM cells
grown in 10% serum resulted in only slight growth stimulation
on both ECM and plastic (1.2-fold). Although FGF was not
potently mitogenic for this primary culture, it still abolished
the inhibitory influence of DEX for cells grown on plastic, in
agreement with our previously reported observation with
cloned cells (7), and greatly reduced the DEX response for
cellsgrown on ECM.
When primary BASM cells were plated on ECM-coated
dishes in 10% serum for 24 h, followed by removal of this
medium and replacement with DME containing human HDL
(250 fig/ml) and transferrin (50 jLg/ml), growth of the cells
was -40% that of cells grown in 10% serum. Cells which were
plated directly in DME-HDL and transferrin grew to -25%
of the control value. Under both of these conditions, DEX
inhibited growth by ~70% (Fig. 4A). The same conditions
for cells plated on plastic (Fig. 4B) resulted in no significant
growth, although the cellsdid attach to the plastic. Cellsgrown
on ECM in heptane-extracted (cholesterol-low) HDL and
transferrin grew as well as on nonheptane extracted HDL,
implying that the growth-promoting role of HDL is not likely
to be the provision ofcholesterol to these cells. DEX addition
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537FIGURE 3 Two-dimensional gel electrophoresis of nascent smooth muscle cell peptides, following glucocorticoid treatment .
Cells were plated and grown for 48 h in the absence (A, C, E, and G) or presence of 10-6M DEX (B, D, F, and H) . Cells were also
plated on ECM-coated dishes (C and D) or grown in the presence of FGF (250 Ag/ml) (G and H) . Cells were labeled for 1 h with
[ 35S]methionine, solubilized, and fractionated on two-dimensional gels as described in Materials and Methods . Circles indicate
the glucocorticoid-induced proteins at pl 5.5, 20,000 mol wt .
FIGURE 4
￿
Growth of primary BASM cells in high density lipoprotein supplemented growth media vs . serum supplemented media
in the presence and absence of dexamethasone . Primary cultures of BASM cells were grown using various supplements to DME-
H16 on either matrix-coated (A) or plastic (B) culture dishes . Cells were plated at 2.0 x 10' cells/35-mm dish and grown for 5 d .
Supplements to the DME were : 10% calf serum plus 250 ng/ml FGF ; 10% calf serum ; 250 yg/ml HDL plus 50 jg/ml transferrin ;
250 jig/ml of heptane-extracted HDL plus 50 A/ml transferrin ; 250 lg/ml HDL plus 50 lAg/ml transferrin (cells plated directly in
this as opposed to plating in 10% serum for 18 h, then changing medium) and no addition to DME . In C, primary BASM cells
were plated in 35-mm dishes coated with ECM in 10% serum . 24 h later, the medium was changed on those cells plated on
matrix to 250 jug/ml HDL and 50 jug/ml transferrin with addition of EFG (50 ng/ml), PDFG (10 jug/ml) or both, as shown . In all
cases the cells were grown for 5 d . Hatched bars indicated the addition of 10' M dexamethasone . The average number of cells
per dish ±SD is shown for two determinations in triplicate .
to these cultures also inhibited growth by -50% .
￿
mitogenic for BASM cells, particularly when the cells are
attached to an ECM . It is also clear that DEX is a potent
influence of Exogenous Growth Factors on
￿
inhibitor of HDL-stimulated BASM cell proliferation and
Serum-free BASM Cell Growth and the
￿
that the growth promotion seen with only HDL and transfer-
GlucOcortiCoid Response
￿
rin in the media is clearly not maximal, relative to that seen
in the presence of serum-supplemented media . This suggests
It is clear from the data of Fig. 4 that factor(s) in HDL are
￿
that other mitogens found in serum may also be required for
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be influenced by glucocorticoids. We therefore tested two
other circulating growth factors known to be mitogenic for
smooth muscle cells, namely EGF and PDGF. As shown in
Fig. 4 C, smooth muscle cells on plastic in the presence of
10% serum were inhibited 62% by DEX. Growth in the
presence of HDL and transferrin alone on ECM was only
30% of that seen with 10% serum, and the DEX-induced
inhibition ofHDL-stimulated growth was 73%.
The addition of EGF (50 ng/ml) to the HDL-transferrin
supplemented medium stimulated growth by 1 .6-fold relative
to control and by 1 .9-fold when DEX was present. The
addition of PDGF (10 Ng/ml) resulted in a 2.7-fold growth
stimulation in the absence ofDEX, but a 5 .4-fold stimulation
in its presence. When both PDGF and EGF were added, the
growth ofBASM cells was comparable to that of 10% serum-
supplemented media. Under these conditions, DEX produced
a 45% inhibition ofgrowth, similarto that seen for cells grown
on ECM in 10% serum. The data show that DEX is still
growth inhibitory in the presence of EGF and PDGF; how-
ever, the growth stimulatory effect of these mitogens, ex-
pressed as a fold increase in cell number, is retained or is
greater that that seen with serum when DEX is present. Thus,
the growth-inhibitory effect of DEX is not abolished by these
mitogens under these growth conditions, as was shown to be
the case for the noncirculating growth factor FGF (Fig. 4A
ar_d B).
DISCUSSION
The studies described above have examined the influence of
the extracellular substrate on the glucocorticoid responsive-
ness of aortic smooth muscle cells. The use ofboth a cloned
strain and primary mass culture shows that these steroids
significantlydecrease both the proliferative rate and saturation
of density of BASM cells when examined on plastic tissue
culture dishes. However, when ECM-coateddishes were used,
the cloned strain was no longer sensitive to glucocorticoid
treatment and the primary mass culture showed a signfcantly
reduced responsiveness. Even so, the primary mass cultures
when grown on ECM-coated dishes attained cell densities that
were 40-50% less in the presence ofDEX than in its absence.
It is reasonable to consider the mass culture as a mixture of
cloned strains, some of which are not responsive to glucocor-
ticoids when plated on ECM-coateddishes and some ofwhich
remain responsive; the mass culture may therefore more
closely reflect the growth responses displayed by these cells in
vivo.
Studies with the cloned BASM cells showed that the ho-
mologous ECM increased the growth rate, especially at low
cell densities, and allowed the cells to remain in logarithmic
growth for longer periods, thus attaining higher saturation
densities. The ECM also significantly increased the sensitivity
of the cells to the mitogenic action of serum, such that cells
grown in 2% serum attained cell densities which were as high
as that of cells grown in 10% serum on plastic. Because the
ECM was able to effectively overcome the glucocorticoid
effect on saturation density, which showed a requirement for
serum concentrations > 1 %, it may be argued that the gluco-
corticoid reduces the cellular sensitivity to some serum factor
and that the ECM simply increases this sensitivity to an extent
greater than the inhibition.
The cloned BASM strain also allowed an evaluation of the
patterns of proteins regulated by glucocorticoids and the
possible correlation of this regulation with the growth re-
sponses. Two peptides in particular at pl about equal to 5.5,
with molecular weights of 20,000, were strongly induced by
DEX only under conditions that resulted in the inhibitory
growth response. Cells grown on ECM or in the presence of
FGF, both of which abolish the glucocorticoid growth re-
sponse of this clone, did not show induction ofthese peptides
by DEX although their constitutive level of expression was
uninfluenced by the ECM or FGF. Although the identifica-
tion, subcellular location, and role in BASM proliferation of
these peptides remain to be determined, their pl and molec-
ular weight as well as their migratory relationships to other
peptides on this gel system are almost identical to those of a
set of nuclear peptides observed in GH, pituitary tumor cells
whose phosphorylation is regulated by glucocorticoids (16). It
should be noted that not all glucocorticoid reponses are
abolished by maintenance ofthese cells on ECM. As described
in the accompanying report (17),the glucocorticoid regulation
of collagen and noncollagen productionby this clone remains
in the absence of a growth response to glucocorticoids. Thus,
the ECM selectively regulates an array of steroid-induced
responses.
The studies with primary mass cultures ofBASM cells have
allowed the investigation of serum mitogens that may be
required for the glucocorticoid responsiveness of a mixed
population of smooth muscle cells. The use of serum-free
conditions and the selective addition of the serum mitogens,
HDL, EGF, and PDGF, has shown that glucocorticoid treat-
ment specifically inhibits the mitogenic action of HDL on
smooth muscle cells. The mitogenic effect of both EGF and
PDGF when added alone or in combination was as great or
greater in the presence of DEX. Under these serum-free
conditions, smooth muscle cell growth was comparable to
that observed when the cells were grown on ECM in the
presence of 10% serum, and the magnitude of the glucocor-
ticoid inhibition was also identical.
At present, it is not known how vascular smooth muscle
cell proliferation is regulated in vivo. However, these findings
and those of our previous studies (7) suggest that endogenous
circulating levels ofglucocorticoids may significantly alterthe
responsiveness of vascular smooth cells to mitogenic stimu-
lation by circulating growth factors. Indeed, myointimal pro-
liferation in response to endothelial denudation in the rabbit
has been shown to be significantly decreased by exogenous
glucocorticoid treatment (8).
The mitogenic activity of HDL observed with smooth
muscle cells in culture is also of great interest to the study of
atherogenesis. HDL is knownto be mitogenic for endothelial
cells (19) and to protect against low density lipoprotein (LDL)
cytotoxicity, and an HDL-LDL balance may be a critical
factor in the susceptibility of individuals to vascular disease
(20, 21). It is of interest that in the present studies heptane-
extracted HDL was found to be equally mitogenic, indicating
that provision of cholesterol is not the major role of HDL in
promoting BASM cell proliferation.
Our initial motivation for initiating these studies was to
investigate a direct glucocorticoid-vascular cell interaction
that might explain the considerable clinical evidence that
hyperglucorcoticoidism constitutes a significant risk factor in
the development of vascular disease (22-24). We reasoned
that glucocorticoids could be considered pro-atherogenic if
they inhibited vascular endothelial cell proliferation and/or
stimulated smooth muscle cell proliferation. The results of
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influence the proliferation of both cell types, glucocorticoids,
per se, have no significant effect on vascular endothelial cell
growth (7, 13) and can only be judged to be growth inhibitory
with respect to smooth muscle cells (7). Although all ofthese
studies have been carried out in vitro, the use of a variety of
different tissue culture conditions, including the use ofECM,
serum-free conditions, clonal, and primary mass cultured
cells, have all confirmedalarge(50-70%) inhibition of BASM
cell proliferation mediated by adirect action ofglucocorticoid
hormones on these cells. On the basis of these observations
we conclude that these steroids are not pro-atherogenic in
terms oftheir ability to influence vascular wall cell prolifera-
tion; however, they may be importantin negatively regulating
the sensitivity of vascular smooth muscle cells to mitogenic
stimulation by circulating growth factors.
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